AIM Immunotech
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • CEO Corner
    • Partnering
  • Science
    • Pipeline
    • Ampligen®
    • Immuno-Oncology
    • Immune Disorders
    • Viral Diseases
    • Orphan Drug Designation
    • Scientific Publications
  • Investors
    • Overview
    • Press Releases
    • Company Info
      • Profile
      • Management Team
    • Presentations
    • Events
    • Stock Information
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Board of Directors
      • Committee Composition
    • Stockholder Meeting
    • Email Alerts
    • Investor Contact
  • Contact Us
Select Page
  • Pipeline
  • Ampligen®
  • Immuno-Oncology
  • Immune Disorders
  • Viral Diseases
  • Orphan Drug Designation
  • Scientific Publications
Pipeline

We are Advancing a Broad Pipeline Across a Number of High-Value Therapeutic Areas

 

Priority Development Pipeline

 

Our Team
Our Science
Email Alerts
Get Notified

Sign up to have the latest news and information delivered directly to your inbox!

Sign Up Now

Contact Us

AIM ImmunoTech
2117 SW Highway 484
Ocala, FL 34473
Phone: 352-448-7797
Fax: 352-480-4620
Email: info@AIMimmuno.com

Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
AIM@jtcir.com

©2025 AIM ImmunoTech     All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Follow
  • Follow
  • Follow